CXCL13 and neoplasm: In conclusion, our study provided evidence that CXCL13 expression in a mouse 4T1 tumor microenvironment triggered effective antitumor immunity by chemoattracting immune cell infiltrations, and CXCL13 could been considered as a novel prognostic marker for TNBC.